Led CimCure's EUR5M seed round for tumor-vasculature-targeting cancer vaccine technology.
Added recently
CimCure is an international biotech company that develops cancer vaccines which directly target and destroy the tumour’s network of blood vessels so that the cancer stops growing and eventually disappears
CimCure is an international biotech company that develops cancer vaccines which directly target and destroy the tumour’s network of blood vessels so that the cancer stops growing and eventually disappears. Through its proprietary Immune-Boost (iBoost) technology, a foreign protein is fused to a protein found on the blood vessels going to the tumour, which, when injected into a patient, leads the body to produce antibodies which attack and destroy the tumour’s blood vessels.